General MedicationsORALGeneric
CELESTONE
BETAMETHASONE
Standard Dose
0.6MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CELESTONE is listed in Drugs@FDA under application 014215 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAMETHASONE Form and strength SYRUP;ORAL - 0.6MG/5ML Sponsor MERCK SHARP DOHME Submission history Latest submission status date: 2006-07-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview CELESTONE is listed in Drugs@FDA under application 014215 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAMETHASONE Form and strength SYRUP;ORAL - 0.6MG/5ML Sponsor MERCK SHARP DOHME Submission history Latest submission status date: 2006-07-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.